Joakim H. Bergstrom

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Reduction of brain stem pathology and transient amelioration of early cognitive symptoms in transgenic mice treated with a monoclonal antibody against α-synuclein oligomers/protofibrils.

Reduction of brain stem pathology and transient amelioration of early cognitive symptoms in transgenic mice treated with a monoclonal antibody against α-synuclein oligomers/protofibrils.

Journal: Aging brain

Published: May 23, 2023

Altered Distribution of SNARE Proteins in Primary Neurons Exposed to Different Alpha-Synuclein Proteoforms.

Altered Distribution of SNARE Proteins in Primary Neurons Exposed to Different Alpha-Synuclein Proteoforms.

Journal: Cellular and molecular neurobiology

Published: March 15, 2023

Studies on alpha-synuclein and islet amyloid polypeptide interaction.

Studies on alpha-synuclein and islet amyloid polypeptide interaction.

Journal: Frontiers in molecular biosciences

Published: October 25, 2022

Reduction of αSYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific Antibody.

Reduction of αSYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific Antibody.

Journal: Pharmaceutics

Published: May 25, 2022

Modeling Parkinson's disease-related symptoms in alpha-synuclein overexpressing mice.

Modeling Parkinson's disease-related symptoms in alpha-synuclein overexpressing mice.

Journal: Brain and behavior

Published: November 30, 2021

ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse models of Parkinson's disease.

ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse models of Parkinson's disease.

Journal: Neurobiology of disease

Published: July 09, 2021

In vivo imaging of alpha-synuclein with antibody-based PET.

In vivo imaging of alpha-synuclein with antibody-based PET.

Journal: Neuropharmacology

Published: July 04, 2021

Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates.

Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates.

Journal: Journal of neuroinflammation

Published: January 15, 2021

Visualization of early oligomeric α-synuclein pathology and its impact on the dopaminergic system in the (Thy-1)-h[A30P]α-syn transgenic mouse model.

Visualization of early oligomeric α-synuclein pathology and its impact on the dopaminergic system in the (Thy-1)-h[A30P]α-syn transgenic mouse model.

Journal: Journal of neuroscience research

Published: January 14, 2021

Age-related increase of alpha-synuclein oligomers is associated with motor disturbances in L61 transgenic mice.

Age-related increase of alpha-synuclein oligomers is associated with motor disturbances in L61 transgenic mice.

Journal: Neurobiology of aging

Published: June 26, 2020

Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson's disease brain.

Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson's disease brain.

Journal: Journal of neuroinflammation

Published: July 11, 2019

Inhibition of nSMase2 Reduces the Transfer of Oligomeric α-Synuclein Irrespective of Hypoxia.

Inhibition of nSMase2 Reduces the Transfer of Oligomeric α-Synuclein Irrespective of Hypoxia.

Journal: Frontiers in molecular neuroscience

Published: May 21, 2019

Showing 1-12 of 40

Last Updated: 09/26/2026